A primer of amyloid nomenclature.
The increasing knowledge of the exact biochemical nature of the localized and systemic amyloid disorders has made a logical and easily understood nomenclature absolutely necessary. Such a nomenclature, biochemically based, has been used for several years but the current literature is still mixed up with many clinical and histochemically based designations from the time when amyloid in general was poorly understood. All amyloid types are today preferably named by their major fibril protein. This makes a simple and rational nomenclature for the increasing number of amyloid disorders known in humans and animals.
Westermark
Per
P
Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden. per.westermark@genpat.uu.se
Benson
Merrill D
MD
Buxbaum
Joel N
JN
Cohen
Alan S
AS
Frangione
Blas
B
Ikeda
Shu-Ichi
S
Masters
Colin L
CL
Merlini
Giampaolo
G
Saraiva
Maria J
MJ
Sipe
Jean D
JD
D000682:Amyloid / Q000145:classification* / Q000378:metabolism; D000686:Amyloidosis / Q000145:classification* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D006801:Humans
D000682:Amyloid